Supergut is a technology company.
Supergut has raised $8.0M across 1 funding round.
Supergut has raised $8.0M in total across 1 funding round.
Supergut has raised $8.0M in total across 1 funding round.
Supergut's investors include Acre Venture Partners, Alpha Edison, Cream City Venture Capital, FINTOP Capital, FirstMark Capital, Startup Mavericks, The Artemis Fund.
Supergut is a technology-driven nutrition company specializing in gut health and appetite control through scientifically formulated prebiotic superfoods delivered as bars, shakes, and fiber boosters. It serves health-conscious consumers seeking to improve digestion, weight management, and metabolic health by addressing the widespread fiber deficiency and leveraging gut microbiome science. The company has demonstrated strong growth momentum, recently expanding retail presence nationwide, including partnerships with major retailers like Walmart and GNC, and achieving rapid sales growth driven by its clinically validated GLP-1 boosting products[1][2][4].
Founded in 2019 by Marc Washington (initially as Muniq), Supergut emerged from a mission to tackle chronic health issues such as prediabetes, diabetes, and obesity through gut-focused nutrition. The idea was rooted in scientific research on prebiotic fibers that stimulate appetite-suppressing gut hormones like GLP-1, mimicking the effects of certain weight loss drugs but in a natural, non-pharmaceutical form. Early traction included direct-to-consumer sales and clinical validation published in a peer-reviewed journal, which helped establish credibility and fuel retail expansion[1][2][3].
Supergut rides the convergence of two major health trends: the growing consumer focus on gut microbiome science and the rising demand for non-pharmaceutical solutions to metabolic health challenges, including obesity and diabetes. The timing is favorable due to increasing awareness of fiber deficiency and side effects of GLP-1 drugs, creating a market opportunity for functional foods that support gut health and appetite control naturally. By bridging nutrition, microbiome science, and consumer convenience, Supergut influences the wellness ecosystem by making evidence-based gut health accessible and mainstream[2][3][6].
Supergut is poised for continued growth as it scales retail distribution and expands product innovation within digestive health. Trends such as personalized nutrition, microbiome-focused wellness, and demand for natural metabolic health solutions will shape its trajectory. With a strong scientific foundation and expanding market presence, Supergut could evolve into a leading player in the functional food and wellness tech space, potentially reaching hundreds of millions in annual revenue. Its influence may extend beyond gut health to broader metabolic and chronic disease management through nutrition[3][4].
This positions Supergut as a transformative company at the intersection of technology, science, and nutrition, redefining how consumers approach gut health and metabolic wellness.
Supergut has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2021 | $8.0M Series A | Acre Venture Partners, Alpha Edison, Cream City Venture Capital, FINTOP Capital, FirstMark Capital, Startup Mavericks, The Artemis Fund |